Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases

• Published in: Joint, bone, spine : revue du rhumatisme Vol. 88; no. 6; pp. 105226 - 4
• Main Authors: Trefond, Ludovic, Drumez, Elodie, Andre, Marc, Costedoat-Chalumeau, Nathalie, Seror, Raphaèle, Devaux, Mathilde, Dernis, Emmanuelle, Dieudonné, Yannick, El Mahou, Soumaya, Lanteri, Aurelia, Melki, Isabelle, Queyrel, Viviane, Roumier, Mathilde, Schmidt, Jean, Barnetche, Thomas, Thomas, Thierry, Cacoub, Patrice, Belot, Alexandre, Aumaitre, Olivier, Richez, Christophe, Hachulla, Eric
• Format: Journal Article
• Language: English
• Published: Elsevier Masson SAS 01.12.2021; Elsevier Masson; Société française de rhumatologie. Published by Elsevier Masson SAS
• Subjects: COVID-19; DMARD; Hydroxychloroquine; Inflammatory rheumatic and musculoskeletal diseases; Letter to the Editor; Life Sciences; Microbiology and Parasitology; SARS COV-2 evolution; SARS CoV-2 tests; COVID-19; Inflammatory rheumatic and musculoskeletal diseases; DMARD; SARS CoV-2 tests; Hydroxychloroquine; SARS COV-2 evolution